AI-generated analysis. Always verify with the original filing.
Abbott Laboratories filed an 8-K on February 20, 2026, disclosing that its Board of Directors amended the first sentence of Article of the Bylaws. The amended and restated Bylaws are effective April 24, 2026, and attached as Exhibit 3.1.
Event Type
Disclosure
Mandatory
Variant
8-K
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On February 20, 2026, Abbott’s Board of Directors amended the first sentence of Articl
Financial Statements and Exhibits. Exhibit No. Exhibit 3.1 By-Laws of Abbott Laboratories, as amended and restated, effective April 24, 2026. 104 Cover Page Int